Cargando…

Clinicopathological significance of CXCR4 in non-small cell lung cancer

BACKGROUND: Emerging evidence indicates that C-X-C chemokine receptor type 4 (CXCR4) is a candidate oncogene in several types of human tumors including non-small cell lung cancer (NSCLC). However, the correlation between CXCR4 expression and clinicopathological characteristics of NSCLC remains uncle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Xiao-ming, He, Lan, Hou, Gang, Jiang, Bing, Wang, Yuan-he, Zhao, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357617/ https://www.ncbi.nlm.nih.gov/pubmed/25834393 http://dx.doi.org/10.2147/DDDT.S71060

Ejemplares similares

Clinicopathological significance of fascin-1 expression in patients with non-small cell lung cancer
por: Ling, Xiao-Ling, et al.
Publicado: (2015)

Clinicopathologic significance of CXCR4 and Nrf2 in colorectal cancer
por: Hu, Tinghua, et al.
Publicado: (2013)

Clinicopathologic Significance of HIF-1α, CXCR4, and VEGF Expression in Colon Cancer
por: Wu, Yugang, et al.
Publicado: (2010)

The clinicopathological significance of FHIT hypermethylation in non-small cell lung cancer, a meta-analysis and literature review
por: Yan, Wei, et al.
Publicado: (2016)

Clinicopathologic Significance of CXCL12 and CXCR4 Expressions in Patients with Colorectal Cancer
por: Yoshuantari, Naomi, et al.
Publicado: (2018)

Clinicopathological and prognostic significance of CXCR4 expression in osteosarcoma: a meta-analysis
por: Kusuma, I Gusti Ngurah Ananda Wira, et al.
Publicado: (2022)

Expression of CXCR4 and VEGF‐C is correlated with lymph node metastasis in non‐small cell lung cancer
por: Bi, Ming Ming, et al.
Publicado: (2017)

Prognostic and clinicopathological significance of NRF2 expression in non-small cell lung cancer: A meta-analysis
por: Wang, Qingsong, et al.
Publicado: (2020)

The clinicopathological significance and ethnic difference of FHIT hypermethylation in non-small-cell lung carcinoma: a meta-analysis and literature review
por: Wu, Xiaoyu, et al.
Publicado: (2016)

Prognostic and clinicopathological significance of Beclin-1 in non-small-cell lung cancer: a meta-analysis
por: Zheng, Tianliang, et al.
Publicado: (2018)

Association between CXCL16/CXCR6 expression and the clinicopathological features of patients with non-small cell lung cancer
por: Ke, Chuangwu, et al.
Publicado: (2017)

Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer
por: Zhou, Lei, et al.
Publicado: (2015)

Clinicopathological Significance of RUNX1 in Non-Small Cell Lung Cancer
por: Kim, Yujin, et al.
Publicado: (2020)

Comprehensive analysis of the immunological implication and prognostic value of CXCR4 in non-small cell lung cancer
por: Guo, Wei, et al.
Publicado: (2022)

Clinicopathological significance of non-small cell lung cancer with high prevalence of Oct-4 tumor cells
por: Chen, Zhenguang, et al.
Publicado: (2012)

Clinicopathological significance of oestrogen receptor expression in non-small cell lung cancer
por: Chen, Xiang-Qi, et al.
Publicado: (2016)

Clinicopathological and prognostic significance of SMAD4 in non-small cell lung cancer: A meta-analysis and database validation
por: Li, Zhiqiang, et al.
Publicado: (2023)

Prognostic value and clinicopathological significance of epithelial cadherin expression in non-small cell lung cancer
por: Qiu, Zhi-Xin, et al.
Publicado: (2015)

Prognostic significance of CXCR4 expression in acute myeloid leukemia
por: Du, Wen, et al.
Publicado: (2019)

CXCR4 Based Therapeutics for Non-Small Cell Lung Cancer (NSCLC)
por: Wald, Ori
Publicado: (2018)

Clinicopathological and prognostic significance of regulatory T cells in patients with non-small cell lung cancer: A systematic review with meta-analysis
por: Zhao, Sha, et al.
Publicado: (2016)

Expression and clinical significance of CXCR5/CXCL13 in human non-small cell lung carcinoma
por: SINGH, RAJESH, et al.
Publicado: (2014)

Identification of CXCR4 Upregulation in Diffuse Large B-Cell Lymphoma Associated with Prognostic Significance and Clinicopathological Characteristics
por: Zhang, Yi-an, et al.
Publicado: (2022)

The clinicopathological and prognostic value of CXCR4 expression in patients with lung cancer: a meta-analysis
por: Qiu, Liping, et al.
Publicado: (2022)

Clinicopathologic significance of the CXCL1-CXCR2 axis in the tumor microenvironment of gastric carcinoma
por: Kasashima, Hiroaki, et al.
Publicado: (2017)

Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis
por: Xu, Lijun, et al.
Publicado: (2015)

CXCR4/CXCL12 in Non-Small-Cell Lung Cancer Metastasis to the Brain
por: Cavallaro, Sebastiano
Publicado: (2013)

Expression and Clinicopathological Significance of SOX11 in Small-Cell Lung Cancer
por: Xinli, Wang, et al.
Publicado: (2022)

MiR-133a is downregulated in non-small cell lung cancer: a study of clinical significance
por: Lan, Dong, et al.
Publicado: (2015)

Clinicopathological significance of DAPK promoter methylation in non-small-cell lung cancer: a systematic review and meta-analysis
por: Zhang, Yan, et al.
Publicado: (2018)

Clinicopathological and prognostic significance of Nanog expression in non-small cell lung cancer: a meta-analysis
por: Huang, Guichuan, et al.
Publicado: (2019)

The association of CXCR4 expression with clinicopathological significance and potential drug target in prostate cancer: a meta-analysis and literature review
por: Chen, Qi, et al.
Publicado: (2015)

Clinicopathological and Prognostic Significance of ABCC3 in Human Glioma
por: Fang, Dan-Dong, et al.
Publicado: (2021)

Correlation between CXCR4, CXCR5 and CCR7 expression and survival outcomes in patients with clinical T1N0M0 non‐small cell lung cancer
por: Yue, Zhao, et al.
Publicado: (2020)

CXCR4 expression in lung carcinogenesis: Evaluating gender-specific differences in survival outcomes based on CXCR4 expression in early stage non-small cell lung cancer patients
por: Fung, Andrea S., et al.
Publicado: (2021)

Change in expressional level and clinicopathological significance of miR-193b-3p in non-small cell lung cancer
por: Xiao, Feng, et al.
Publicado: (2023)

CXCR4 antagonists suppress small cell lung cancer progression
por: Taromi, Sanaz, et al.
Publicado: (2016)

Clinicopathological characteristics and prognostic significance of HDAC11 protein expression in non-small cell lung cancer: a retrospective study
por: Lu, Di, et al.
Publicado: (2022)

Clinicopathologic characteristics and outcomes of Chinese patients with non‐small‐cell lung cancer and BRAF mutation
por: Ding, Xi, et al.
Publicado: (2017)

Clinicopathological significance of CHFR methylation in non-small cell lung cancer: a systematic review and meta-analysis
por: Wang, Chen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jpnsnsdurhvo76g9ojj47ldtoe